These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. RAC1 Lionarons DA; Hancock DC; Rana S; East P; Moore C; Murillo MM; Carvalho J; Spencer-Dene B; Herbert E; Stamp G; Damry D; Calado DP; Rosewell I; Fritsch R; Neubig RR; Molina-Arcas M; Downward J Cancer Cell; 2019 Jul; 36(1):68-83.e9. PubMed ID: 31257073 [TBL] [Abstract][Full Text] [Related]
7. PIK3CA-mutated melanoma cells rely on cooperative signaling through mTORC1/2 for sustained proliferation. Silva JM; Deuker MM; Baguley BC; McMahon M Pigment Cell Melanoma Res; 2017 May; 30(3):353-367. PubMed ID: 28233937 [TBL] [Abstract][Full Text] [Related]
8. Oncogenic mutations on Rac1 affect global intrinsic dynamics underlying GTP and PAK1 binding. Acuner SE; Sumbul F; Torun H; Haliloglu T Biophys J; 2021 Mar; 120(5):866-876. PubMed ID: 33515600 [TBL] [Abstract][Full Text] [Related]
9. Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints. Cannon AC; Budagyan K; Uribe-Alvarez C; Kurimchak AM; Araiza-Olivera D; Cai KQ; Peri S; Zhou Y; Duncan JS; Chernoff J Oncogene; 2024 Mar; 43(10):729-743. PubMed ID: 38243078 [TBL] [Abstract][Full Text] [Related]
10. DOCK1 inhibition suppresses cancer cell invasion and macropinocytosis induced by self-activating Rac1 Tomino T; Tajiri H; Tatsuguchi T; Shirai T; Oisaki K; Matsunaga S; Sanematsu F; Sakata D; Yoshizumi T; Maehara Y; Kanai M; Cote JF; Fukui Y; Uruno T Biochem Biophys Res Commun; 2018 Feb; 497(1):298-304. PubMed ID: 29432733 [TBL] [Abstract][Full Text] [Related]
11. RAC1P29S is a spontaneously activating cancer-associated GTPase. Davis MJ; Ha BH; Holman EC; Halaban R; Schlessinger J; Boggon TJ Proc Natl Acad Sci U S A; 2013 Jan; 110(3):912-7. PubMed ID: 23284172 [TBL] [Abstract][Full Text] [Related]
12. Mechanistic Differences of Activation of Rac1 Senyuz S; Jang H; Nussinov R; Keskin O; Gursoy A J Phys Chem B; 2021 Apr; 125(15):3790-3802. PubMed ID: 33848152 [TBL] [Abstract][Full Text] [Related]
13. Enhanced Dendritic Actin Network Formation in Extended Lamellipodia Drives Proliferation in Growth-Challenged Rac1 Mohan AS; Dean KM; Isogai T; Kasitinon SY; Murali VS; Roudot P; Groisman A; Reed DK; Welf ES; Han SJ; Noh J; Danuser G Dev Cell; 2019 May; 49(3):444-460.e9. PubMed ID: 31063759 [TBL] [Abstract][Full Text] [Related]
14. Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells. Jung ID; Lee J; Lee KB; Park CG; Kim YK; Seo DW; Park D; Lee HW; Han JW; Lee HY Eur J Biochem; 2004 Apr; 271(8):1557-65. PubMed ID: 15066181 [TBL] [Abstract][Full Text] [Related]
15. RAC1 and melanoma. Halaban R Clin Ther; 2015 Mar; 37(3):682-5. PubMed ID: 25465943 [TBL] [Abstract][Full Text] [Related]
16. Concomitant Inhibition of PI3Kβ and BRAF or MEK in PTEN-Deficient/BRAF-Mutant Melanoma Treatment: Preclinical Assessment of SAR260301 Oral PI3Kβ-Selective Inhibitor. Bonnevaux H; Lemaitre O; Vincent L; Levit MN; Windenberger F; Halley F; Delorme C; Lengauer C; Garcia-Echeverria C; Virone-Oddos A Mol Cancer Ther; 2016 Jul; 15(7):1460-71. PubMed ID: 27196754 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells. Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766 [TBL] [Abstract][Full Text] [Related]
19. The role of PI3'-lipid signalling in melanoma initiation, progression and maintenance. Parkman GL; Foth M; Kircher DA; Holmen SL; McMahon M Exp Dermatol; 2022 Jan; 31(1):43-56. PubMed ID: 34717019 [TBL] [Abstract][Full Text] [Related]